Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Eplerenone tablets | ||
|
Eslicarbazepine tablets | ESCA. MHRA - Category 2 |
|
|
Ethosuximide capsules | MHRA - Category 3 |
|
|
Evra (patches) | Umbrella service only - patients with compliance problems and metabolic problems |
|
|
Exemestane tablets | ||
|
Fentanyl patches | ||
|
Ferric maltol (Feraccru®) | For the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD), unable to tolerate other oral iron formulations. Supported by a RICaD |
|
|
Flash glucose monitoring system (FreeStyle Libre 2®, FreeStyle Libre®) | ||
|
Flecainide injection | Hospital only |
|
|
Flucitasone inhaler (Flixotide) evohaler 125 / Fluticasone accuhaler 250 | For paediatric use only |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
